
Beyond diabetes: Semaglutide's surprising signal in bipolar disorder
Semaglutide, a GLP-1 receptor agonist, shows an unexpected signal for mood stabilization in patients with bipolar disorder, raising questions about its broader therapeutic potential.
Is the global loneliness epidemic a real phenomenon or a perception problem?
Research into global loneliness reveals a complex picture, challenging the notion of a universal epidemic and highlighting regional and demographic variations.
Your unread medical textbooks aren't a failure, they're a psychological tool
The phenomenon of acquiring books without reading them, known as tsundoku, offers psychological benefits related to aspiration and potential.
Borderline personality disorder: where medication helps and where it does not
Off-label prescribing for psychiatric inpatients with intellectual disability is common, with psychotropics frequently used for unlicensed indications.
Esketamine vs. Quetiapine: Which Augmentation Strategy for TRD?
A head-to-head trial compared esketamine and quetiapine as augmentation strategies for treatment-resistant depression, offering insights into their relative efficacy and tolerability.
Deep TMS for OCD: How durable is the response in treatment-resistant patients?
Deep transcranial magnetic stimulation offers a non-invasive option for treatment-resistant OCD, but questions remain about the long-term durability of its effects.
Personality Disorder: The Shift from Categorical to Dimensional Diagnosis
The field of personality disorder diagnosis is moving towards a dimensional model, offering a more precise understanding of patient presentations beyond traditional categories.
Off-label prescribing in borderline personality disorder: where medication helps and where it does not
Off-label prescribing of psychotropics for psychiatric inpatients with intellectual disability is common, with a survey identifying specific drug classes used for unlicensed indications.
Dialectical Behaviour Therapy: Does Brief Intervention Hold Up Long-Term?
Long-term psychological treatments are recommended for personality disorders, but brief interventions show uncertain long-term benefit for borderline personality disorder.